In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma

Molecular Cancer

Research

Zhongming Zhao¹  Yaomin Xu²  Xingyi Guo³ 

[1] Department of Biomedical Informatics, Vanderbilt University School of Medicine, 37203, Nashville, TN, USA;Center for Quantitative Sciences, Vanderbilt University Medical Center, 37232, Nashville, TN, USA;Department of Cancer Biology, Vanderbilt University School of Medicine, 37232, Nashville, TN, USA;Department of Biomedical Informatics, Vanderbilt University School of Medicine, 37203, Nashville, TN, USA;Department of Biostatistics, Vanderbilt University School of Medicine, 37203, Nashville, TN, USA;Center for Quantitative Sciences, Vanderbilt University Medical Center, 37232, Nashville, TN, USA;Department of Biomedical Informatics, Vanderbilt University School of Medicine, 37203, Nashville, TN, USA;Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 37232, Nashville, TN, USA;

关键词: Melanoma;    Expression;    DNA methylation;    Driver mutation;    BRAF;    MITF;    TGFB1;    DNMT3A;   

DOI  :  10.1186/s12943-015-0328-y

 received in 2014-10-28, accepted in 2015-02-26,  发布年份 2015

来源: Springer

【 摘 要 】

BackgroundThe recurrent BRAF driver mutation V600E (BRAFV600E) is currently one of the most clinically relevant mutations in melanoma. However, the genome-wide transcriptional and epigenetic dysregulations induced by BRAFV600E are still unclear. The investigation of this driver mutation’s functional consequences is critical to the understanding of tumorigenesis and the development of therapeutic strategies.Methods and resultsWe performed an integrative analysis of transcriptomic and epigenomic changes disturbed by BRAFV600E by comparing the gene expression and methylation profiles of 34 primary cutaneous melanoma tumors harboring BRAFV600E with those of 27 BRAFWT samples available from The Cancer Genome Atlas (TCGA). A total of 711 significantly differentially expressed genes were identified as putative BRAFV600E target genes. Functional enrichment analyses revealed the transcription factor MITF (p < 3.6 × 10−16) and growth factor TGFB1 (p < 3.1 × 10−9) were the most significantly enriched up-regulators, with MITF being significantly up-regulated, whereas TGFB1 was significantly down-regulated in BRAFV600E, suggesting that they may mediate tumorigenesis driven by BRAFV600E. Further investigation using the MITF ChIP-Seq data confirmed that BRAFV600E led to an overall increased level of gene expression for the MITF targets. Furthermore, DNA methylation analysis revealed a global DNA methylation loss in BRAFV600E relative to BRAFWT. This might be due to BRAF dysregulation of DNMT3A, which was identified as a potential target with significant down-regulation in BRAFV600E. Finally, we demonstrated that BRAFV600E targets may play essential functional roles in cell growth and proliferation, measured by their effects on melanoma tumor growth using a short hairpin RNA silencing experimental dataset.ConclusionsOur integrative analysis identified a set of BRAFV600E target genes. Further analyses suggested a complex mechanism driven by mutation BRAFV600E on melanoma tumorigenesis that disturbs specific cancer-related genes, pathways, and methylation modifications.

【 授权许可】

Unknown   
© Guo et al.; licensee BioMed Central. 2015. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.